ORGANOGENESIS HOLDINGS INC. Total Assets
ORGANOGENESIS HOLDINGS INC. (ORGO) had Total Assets of $406.45 million as of 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Balance Sheet › Assets
us-gaap:Assets · last filed 2026-08-06
- 2026-06-30: Assets $406.45M.
- 2026-03-31: Assets $519.99M.
- 2025-12-31: Assets $598.73M.
- 2025-09-30: Assets $509.83M.
| Period end | Assets | Assets as first filed |
|---|---|---|
| 2026-06-30 | $406.45M 10-Q · filed 2026-08-06 | |
| 2026-03-31 | $519.99M 10-Q · filed 2026-05-07 | |
| 2025-12-31 | $598.73M 10-Q · filed 2026-08-06 | |
| 2025-09-30 | $509.83M 10-Q · filed 2025-11-06 | |
| 2025-06-30 | $461.13M 10-Q · filed 2025-08-07 | |
| 2025-03-31 | $467.39M 10-Q · filed 2025-05-08 | |
| 2024-12-31 | $497.89M 10-K · filed 2026-02-26 | |
| 2024-09-30 | $446.30M 10-Q · filed 2024-11-12 | |
| 2024-06-30 | $443.16M 10-Q · filed 2024-08-08 | |
| 2024-03-31 | $458.48M 10-Q · filed 2024-05-09 | |
| 2023-12-31 | $460.02M 10-K · filed 2025-02-27 | |
| 2023-09-30 | $462.65M 10-Q · filed 2023-11-09 | |
| 2023-06-30 | $450.31M 10-Q · filed 2023-08-09 | |
| 2023-03-31 | $446.11M 10-Q · filed 2023-05-10 | |
| 2022-12-31 | $449.36M 10-K · filed 2024-02-29 | |
| 2022-09-30 | $457.27M 10-Q · filed 2022-11-09 | |
| 2022-06-30 | $456.36M 10-Q · filed 2022-08-09 | |
| 2022-03-31 | $436.27M 10-Q · filed 2022-05-10 | |
| 2021-12-31 | $443.26M 10-K · filed 2023-03-01 | |
| 2021-09-30 | $370.42M 10-Q · filed 2021-11-09 | |
| 2021-06-30 | $355.56M 10-Q · filed 2021-08-09 | |
| 2021-03-31 | $319.18M 10-Q · filed 2021-05-11 | |
| 2020-12-31 | $290.22M 10-K · filed 2022-03-01 | $294.49M 10-K · filed 2021-03-16 |
| 2020-09-30 | $246.43M 10-Q · filed 2020-11-09 | |
| 2020-06-30 | $216.49M 10-Q · filed 2020-08-10 | |
| 2020-03-31 | $208.34M 10-Q · filed 2020-05-11 | |
| 2019-12-31 | $220.69M 10-K · filed 2021-03-16 | |
| 2019-09-30 | $174.64M 10-Q · filed 2019-11-12 | |
| 2019-06-30 | $168.07M 10-Q · filed 2019-08-09 | |
| 2019-03-31 | $176.45M 10-Q · filed 2019-05-10 | |
| 2018-12-31 | $163.68M 10-K · filed 2020-03-09 | |
| 2018-09-30 | $316.31M 10-Q · filed 2018-11-09 | |
| 2018-06-30 | $314.98M 10-Q · filed 2018-08-07 | |
| 2018-03-31 | $313.79M 10-Q · filed 2018-05-10 | |
| 2017-12-31 | $148.72M 10-K · filed 2019-03-18 | $312.79M 10-K · filed 2018-03-14 |
| 2017-09-30 | $312.06M 10-Q · filed 2017-11-14 | |
| 2017-06-30 | $311.56M 10-Q · filed 2017-08-11 | |
| 2017-03-31 | $311.24M 10-Q · filed 2017-05-12 | |
| 2016-12-31 | $311.44M 10-K · filed 2018-03-14 | |
| 2016-09-30 | $821.88K 10-Q · filed 2016-11-18 | |
| 2015-12-31 | $416.27K 10-K · filed 2017-03-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| AN2 Therapeutics, Inc. (ANTX) | United States | $0.185B | -4.84 |
| PepGen Inc. (PEPG) | United States | $0.186B | -1.73 |
| ALX ONCOLOGY HOLDINGS INC (ALXO) | United States | $0.187B | -3.52 |
| Fortress Biotech, Inc. (FBIO) | United States | $0.188B | 0.91 |
| Zentalis Pharmaceuticals, Inc. (ZNTL) | United States | $0.196B | -2.48 |
| Tonix Pharmaceuticals Holding Corp. (TNXP) | United States | $0.166B | -1.34 |
| Minerva Neurosciences, Inc. (NERV) | United States | $0.165B | -0.66 |
| ORAMED PHARMACEUTICALS INC. (ORMP) | $0.199B | 1.13 | |
| ADC Therapeutics SA (ADCT) | $0.163B | -1.39 | |
| LIFECORE BIOMEDICAL, INC. DE (LFCR) | United States | $0.163B | -8.50 |